Longitudinal Study on the Influence of Iodine Nutrition Status on Thyroid Function of Childbearing Age Women During Pregnancy and 6 Weeks Postpartum
1 other identifier
observational
2,100
1 country
1
Brief Summary
The goal of this observational study is to provide a reference for formulating individual appropriate iodine intake programs for women during pregnancy and postpartum and improving the monitoring and evaluation system of maternal iodine nutrition status. The main questions it aims to answer are:
- To analyse the longitudinal changes of urinary iodine, urinary iodine/creatinine ratio, thyroid function and related factors in different periods of early, middle, late pregnancy and 6 weeks postpartum in Beijing area.
- To explore the relationship between iodine nutrition status and the changes of thyroid function and to further clarify the effect of iodine nutrition status on thyroid function of women of childbearing age during pregnancy and postpartum in combination with dietary intake of iodine questionnaire. Participants will be detected there thyroid function, the level of median urinary iodine and urinary iodine/creatinine. Researchers will compare healthy women of childbearing age served as the control group in the same period.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 30, 2022
CompletedFirst Posted
Study publicly available on registry
January 10, 2023
CompletedStudy Start
First participant enrolled
November 15, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2024
CompletedMay 10, 2024
November 1, 2023
1.1 years
November 30, 2022
May 8, 2024
Conditions
Outcome Measures
Primary Outcomes (4)
Data of pregnant women in the early trimester of pregnancy
detect the level of serum TSH, FT4, TPOAb, TGAb and the level of median urinary iodine and urinary iodine/creatinine
Any day between weeks 8 and 12 of gestation
Data of pregnant women in the middle trimester of pregnancy
detect the level of serum TSH, FT4, TPOAb, TGAb and the level of median urinary
Any day between weeks 24 and 28 of gestation
Data of pregnant women in the third trimester of pregnancy
detect the level of serum TSH, FT4, TPOAb, TGAb and the level of median urinary
Any day between weeks 36 of gestation to the day before parturition
Data of postpartum women
detect the level of serum TSH, FT4, TPOAb, TGAb and the level of median urinary
6 weeks after parturition
Study Arms (2)
pregnancy and lactation period women
healthy women of childbearing age
Interventions
iodine nutrition status
Eligibility Criteria
maternal and women of childbearing age in Beijing area
You may qualify if:
- primigravida
- no chronic hypertension, thromboembolic disease, severe gastrointestinal, cardiopulmonary and liver diseases before pregnancy
- no systemic lupus erythematosus, rheumatic diseases and other connective tissue diseases or immune diseases before pregnancy
- no adrenocortical hyperplasia, pituitary endocrine diseases and other diseases before pregnancy
You may not qualify if:
- multiple pregnancies and multigravida
- a history of type I or type II diabetes before pregnancy
- a clear history of thyroid diseases before pregnancy
- taking drugs that affect thyroid function and/or blood sugar before or during early pregnancy
- Healthy women of childbearing age:
- years old
- no chronic hypertension, thromboembolic disease, severe gastrointestinal, cardiopulmonary and liver diseases
- no systemic lupus erythematosus, rheumatic diseases and other connective tissue diseases or immune diseases
- no adrenocortical hyperplasia, pituitary endocrine diseases and other diseases
- a history of type I or type II diabetes
- a clear history of thyroid diseases
- taking drugs that affect thyroid function and/or blood sugar
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Beijing Friendship Hospital ,Capital Medical University
Beijing, China
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 30, 2022
First Posted
January 10, 2023
Study Start
November 15, 2023
Primary Completion
December 31, 2024
Study Completion
December 31, 2024
Last Updated
May 10, 2024
Record last verified: 2023-11
Data Sharing
- IPD Sharing
- Will not share